Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Search

Top

PATHEON DEVELOPMENT SERVICES INC.

Subsidiary ofTHERMO ELECTRON CORPORATIONUEI: TKM6CSVM9215

PATHEON DEVELOPMENT SERVICES INC. is a federal contractor, registered under UEI TKM6CSVM9215. It has been awarded $92,222 in federal contracts. Primary work spans Pharmaceutical Preparation Manufacturing. Top awarding agencies include Department Of Health And Human Services.

Contact Information

Registration and classification details

Registration

UEI Code

TKM6CSVM9215

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

2

All time

Active

0

Currently performing

Completed

2

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$92.2K100%

Awards by NAICS

325412 - Pharmaceutical Preparation Manufacturing$92.2K100%

Awards by Agency Over Time

Awards by Place of Performance

Compete with PATHEON DEVELOPMENT SERVICES INC.

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for PATHEON DEVELOPMENT SERVICES INC.

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in PATHEON DEVELOPMENT SERVICES INC.'s top NAICS codes and agencies

Supplier of Red Sealing Compound (NSN 8030015650423)

Defense Logistics Agency

POSTED

about 16 hours ago

DEADLINE

Supply of 4% Chlorhexidine Gluconate Surgical Detergent

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

Isoniazid Tablet Manufacturing

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

DETERGENT, SURGICAL

Solicitation # SPE2DP-27-T-0122

Solicitation SPE2DP-27-T-0122 is a procurement request by the Defense Logistics Agency for surgical detergent containing 4% chlorhexidine gluconate, identified by NSN 6505-01-101-3759. The requirement is for one 8 oz bottle to be delivered FOB Destination to the USNS ABLE TAGOS 20. The item is FDA regulated and must have a total shelf life of 24 months, with at least 21 months remaining upon delivery to the government. The original required delivery date is October 21, 2026, with a delivery lead time of 20 days after award. The contract mandates strict adherence to Medical Marking Standard No. 1C and DLA packaging requirements RP001. Packaging must be commercial, utilizing sealed unit containers and suitable exterior shipping containers. If the material is deemed hazardous per FED-STD-313, it must follow TQ requirement IP025; otherwise, it must comply with ASTM D3951. Offerors must submit quotes via DIBBS by October 26, 2026, and provide a Safety Data Sheet meeting 29 CFR 1910.1200(g) prior to award. The procurement is subject to destination inspection under FAR 52.246-2 and incorporates the Buy American Act and HUBZone price evaluation preferences. Invoicing and receiving reports must be processed through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

TETRAHYDROZOLINE HYDRO

Solicitation # SPE2DP-27-T-0130

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

TOLNAFTATE POWDER

Solicitation # SPE2DP-27-T-0126

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

ENROFLOXACIN INJECTION

Solicitation # SPE2DP-27-T-0128

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

CHARCOAL, ACTIVATED, SUS

Solicitation # SPE2DP-27-T-0125

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

ISONIAZID TABLETS

Solicitation # SPE2DP-27-T-0123

Solicitation SPE2DP-27-T-0123 is a request for quotations from the DLA Troop Support Medical Supply Chain Pharm FSA for the procurement of Isoniazid Tablets, USP, 300 MG. The requirement consists of two line items totaling three bottles, with each bottle containing 100 tablets. The items must be stored at medical controlled room temperature and have a non-extendable shelf life of 36 months. Delivery is required within 20 days after order, with an original required delivery date of October 21, 2026. Shipments are destined for the USS Lewis B Puller ESB 3 and the USS Kingsville LCS 36, with FOB and inspection/acceptance points set at the destination. The contract mandates strict adherence to DLA packaging and marking standards, including MIL-STD-129 and Medical Marking Standard No. 1. Palletization must follow RP001, and non-hazardous materials must be packaged per ASTM D3951, though the DLA Master List of Technical and Quality Requirements takes precedence. The procurement is governed by NAICS code 325412 and includes various FAR and DFARS clauses regarding fixed-price supply, safeguarding covered defense information, and the Buy American Act. Invoicing must be processed electronically through the Wide Area WorkFlow system.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

MOXIFLOXACIN HYDROCHLO

Solicitation # SPE2DP-27-T-0127

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

BUPIVACAINE AND EPINEP

Solicitation # SPE2DP-27-T-0124

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

about 16 hours ago

DEADLINE

Supply of Decomax (Doramectin) Injectable Solution

Mrpbs Minneapolis Mn

POSTED

about 21 hours ago

DEADLINE

cGMP Drug Substance & Product Manufacturing

POSTED

about 21 hours ago

DEADLINE

6505--FY27 Low Energy General Radiopharmaceuticals 36C25027Q0052

Solicitation # 36C25027Q0052

The Department of Veterans Affairs is conducting market research through a Sources Sought Notice to identify qualified providers for unit-dose, patient-specific low energy radiopharmaceutical products, excluding FDG F-18 agents. These products will support diagnostic nuclear medicine imaging and therapeutic procedures at the VA Northeast Ohio Healthcare System in Cleveland and the VA Kent Imaging and Infusion Center in Kent, Ohio. The anticipated period of performance begins January 1, 2027, and extends through December 31, 2031, consisting of a base year and four 12-month option years. The requirement involves the supply of various radiopharmaceuticals, including Technetium-99m and Iodine-123 agents, with specific annual estimated quantities for each. A critical operational requirement is the ability to fulfill emergent orders within 120 minutes of receipt for both locations. All products must be compounded and calibrated under the supervision of a certified Nuclear Pharmacist in accordance with USP 797 and USP 825 standards, and must comply with regulations from the FDA, NRC, DOT, and the Joint Commission. Interested respondents must be registered in SAM.gov and possess all necessary NRC, FDA, and DOT licenses for the transport and distribution of radioactive materials. The government is specifically seeking to determine the availability of Service-Disabled Veteran-Owned Small Businesses and other small business concerns under NAICS 325412 to inform the final acquisition strategy and potential set-aside determinations. Responses are due by 9:00 AM Eastern Time on November 3, 2026.

250-NETWORK Contract Office 10 (36C250)

POSTED

about 21 hours ago

DEADLINE

Manufacturer of Ultrasonic Dental Cleaning CompoundsThis subcontract involves the chemical formulation and production of Maxizyme enzyme cleaning tablets intended for prime contractors supporting Defense Logistics Agency medical supply contracts. The scope of work encompasses the full manufacturing process, including chemical synthesis, the formulation of enzyme cleaners specifically for ultrasonic dental cleansing, and the compression of these compounds into final tablet form using specialized chemical processing equipment and tablet presses. The manufacturer is required to adhere strictly to the DLA Master List of Technical and Quality Requirements as well as Medical Marking Standard No. 1 to ensure regulatory compliance. The final deliverable consists of packaged Maxizyme Tablets provided to the Department of Defense via the Medical Supply Chain. This opportunity falls under NAICS code 325412 and is managed through the DLA system.

MEDICAL SUPPLY CHAIIN FSH

POSTED

DEADLINE

Supply of Electrical Insulation Tape (NSN 5970-01-258-1216)This subcontract involves the supply of electrical insulation tape for prime contractors working under the Defense Logistics Agency Weapons Support ASC Supplier Oper AE and AF Division. The selected provider is responsible for manufacturing or sourcing tape that strictly adheres to technical specifications for NSN 5970-01-258-1216. All deliverables must be packaged according to RP001 standards and marked and labeled in compliance with RQ017 requirements, necessitating the use of packaging facilities capable of meeting these specific DLA standards. The opportunity is categorized under NAICS code 325412 and is managed by the Department of Defense. Performance of the contract will take place in APO 96328-5120. Interested parties must note the response deadline of October 26, 2026, to submit their proposals for the delivery of these physical materials.

DLA WEAPONS SUPPORT ASC SUPPLIER OPER AE AND AF DIV

POSTED

DEADLINE

Supply of Orange Flavored Electrolyte Oral Hydration PowderThis subcontract involves the manufacture or distribution of medical-grade orange-flavored electrolyte oral hydration powder to support prime contractors for the Department of Defense Medical Supply Chain Pharm FSA. The required product must meet NSN 6505016871441, provided in 21 GM units packaged in quantities of 100, while adhering to Medical Marking Standard No. 1 and commercial packing standards. The contract mandates strict compliance with the Buy American Act, the Berry Amendment, and NIST SP 800-171 cybersecurity standards. Performance takes place at FPO 09591-2600, with a response deadline of October 26, 2026.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE

Supply of Lactated Ringer's InjectionThis subcontract involves the supply of Lactated Ringer's Injection, USP, 1000ML, 12S for prime contractors supporting the Department of Defense Medical Supply Chain Pharm FSA. The selected provider must manufacture or wholesale these medical fluids in accordance with USP standards and FDA regulations, ensuring a minimum shelf life of 30 months. All products must be packaged in commercial sealed units following MIL-STD-2073-1E and RP001 guidelines and marked according to Medical Marking Standard No. 1. The contract requires delivery of completed orders FOB Destination to a performance location in FPO 96660. Interested parties must respond by October 26, 2026, for this requirement categorized under NAICS code 325412.

MEDICAL SUPPLY CHAIN PHARM FSA

POSTED

DEADLINE